Mark Cavendish wins second consecutive stage in Tour du Poitou Charentes
Mark Cavendish underlines return to form with victory on stage two of French race to extend overall lead

Mark Cavendish in the Tour du Poitou Charentes 2014
Mark Cavendish (Omega Pharma-QuickStep) won his second consecutive stage of the Tour du Poitou Charentes in France on Wednesday.
Cavendish got the better of Movistar fastman Enrique Sanz with Frenchman Lorenzo Manzin (FDJ) in third. The Manx sprinter's consistent performance shows that he has firmly put his Tour de France shoulder injury behind him.
Cavendish earned himself more bonus seconds to extend his lead in the general classification. He now sits 14 seconds ahead of second-placed Sanz, with Maxime Daniel (Ag2r) in third at the same time.
The UCI 2.1-ranked Tour du Poitou Charentes concludes on Saturday, August 30. Cavendish will then take part in the 2014 Tour of Britain, kicking off in Liverpool on September 7.
Mark Cavendish wins stage one of Tour du Poitou Charentes
Manxman Mark Cavendish takes first win since crashing out of the Tour de France in July
British professional road wins 2014
We keep track of British riders' victories in international professional races during the 2014 season
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.